Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
120Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $30.91M | $-74.28M | $-1.18 |
| 2024 | $22.60M | $-86.62M | $-1.58 |
| 2023 | $34.16M | $-98.43M | $-2.34 |
| 2022 | $19.23M | $-108.88M | $-2.62 |
| 2021 | $1.32M | $-101.32M | $-2.78 |
Social Signal Score
Earnings
Wed, Nov 4(in 3 months)
Consensus estimate $-0.23 per share
Typical surprise +9.7% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$-0.10 vs $-0.24beat
- Thu, May 7$-0.29 vs $-0.28miss
- Wed, Mar 11$-0.34 vs $-0.28miss
- Wed, Nov 5$-0.25 vs $-0.31beat
- Tue, Aug 5$-0.28 vs $-0.31beat
- Wed, May 14$-0.30 vs $-0.30beat
Estimates and results for FHTX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
FHTXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newszacks.com·1d ago·Positive
Here's Why Foghorn Therapeutics Inc. (FHTX) is a Great Momentum Stock to Buy Does Foghorn Therapeutics Inc. (FHTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
View source ↗